ANDREW SCHAFER

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Thrombocytosis
    Andrew I Schafer
    Department of Medicine, University of Pennsylvania School of Medicine and University of Pennsylvania Health System, Philadelphia 19104, USA
    N Engl J Med 350:1211-9. 2004
  2. ncbi Crafting an effective strategic plan for a department of medicine
    Andrew I Schafer
    Department of Medicine at the University of Pennsylvania School of Medicine, Philadelphia, USA
    Am J Med 118:315-20. 2005
  3. ncbi Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia
    Andrew I Schafer
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Blood 107:4214-22. 2006
  4. ncbi Thrombocytosis: When is an incidental finding serious?
    Andrew I Schafer
    Department of Medicine, University of Pennsylvania School of Medicine, Hospital of University of Pennsylvania, Philadelphia, PA 19104, USA
    Cleve Clin J Med 73:767-74. 2006
  5. ncbi Thrombocytosis: too much of a good thing?
    Andrew I Schafer
    Department of Medicine, The Bob and Vivian Smith Professor of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Trans Am Clin Climatol Assoc 113:68-76; discussion 76-7. 2002
  6. ncbi YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function
    David A Tulis
    Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Biochem Biophys Res Commun 291:1014-21. 2002
  7. ncbi The fault lines of academic medicine
    Andrew I Schafer
    Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Perspect Biol Med 45:416-25. 2002
  8. ncbi Genetic and acquired determinants of individual variability of response to antiplatelet drugs
    Andrew I Schafer
    Circulation 108:910-1. 2003
  9. ncbi Physiologic cyclic stretch inhibits apoptosis in vascular endothelium
    Xiao-ming Liu
    VA Medical Center and the Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    FEBS Lett 541:52-6. 2003

Research Grants

  1. REGULATION OF PLATELET/ENDOTHELIAL INTERACTIONS
    ANDREW SCHAFER; Fiscal Year: 2001
  2. VASCULAR CELL CATIONIC AMINO ACID TRANSPORT & METABOLISM
    ANDREW SCHAFER; Fiscal Year: 2002
  3. REGULATION OF PLATELET-ENDOTHELIAL INTERACTIONS
    ANDREW SCHAFER; Fiscal Year: 2006
  4. REGULATION OF PLATELET-ENDOTHELIAL INTERACTIONS
    ANDREW SCHAFER; Fiscal Year: 1993
  5. Revitalization of the Nation?s Physician-Scientist Workforce
    ANDREW SCHAFER; Fiscal Year: 2007

Collaborators

  • Xiao-ming Liu
  • William Durante
  • David A Tulis
  • Hong Wang
  • Diana Ensenat
  • Jennifer L West
  • Alida J Evans
  • Elizabeth A Lipke
  • Kelly J Peyton
  • Rachel L Schiesser
  • Kristyn S Bohl Masters

Detail Information

Publications9

  1. ncbi Thrombocytosis
    Andrew I Schafer
    Department of Medicine, University of Pennsylvania School of Medicine and University of Pennsylvania Health System, Philadelphia 19104, USA
    N Engl J Med 350:1211-9. 2004
  2. ncbi Crafting an effective strategic plan for a department of medicine
    Andrew I Schafer
    Department of Medicine at the University of Pennsylvania School of Medicine, Philadelphia, USA
    Am J Med 118:315-20. 2005
  3. ncbi Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia
    Andrew I Schafer
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Blood 107:4214-22. 2006
    ....
  4. ncbi Thrombocytosis: When is an incidental finding serious?
    Andrew I Schafer
    Department of Medicine, University of Pennsylvania School of Medicine, Hospital of University of Pennsylvania, Philadelphia, PA 19104, USA
    Cleve Clin J Med 73:767-74. 2006
    ..This article discusses how to classify thrombocytosis and identify which patients require treatment, describes the characteristic complications that may arise, and provides an algorithm for management...
  5. ncbi Thrombocytosis: too much of a good thing?
    Andrew I Schafer
    Department of Medicine, The Bob and Vivian Smith Professor of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Trans Am Clin Climatol Assoc 113:68-76; discussion 76-7. 2002
    ..It is proposed that bleeding and thrombosis could be due to vascular abnormalities that result from dysfunctional hematopoietic stem cell-derived endothelial cells...
  6. ncbi YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function
    David A Tulis
    Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Biochem Biophys Res Commun 291:1014-21. 2002
    ..These results suggest that YC-1 is a potent, physiologically active agent with major anti-proliferative and anti-platelet properties that may provide protection against vascular injury through cGMP-dependent mechanisms...
  7. ncbi The fault lines of academic medicine
    Andrew I Schafer
    Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Perspect Biol Med 45:416-25. 2002
    ..The organization of a successful medical school or department must be dynamic, constantly serving its constituents to accommodate progress and change and to promote optimal structure for academic productivity...
  8. ncbi Genetic and acquired determinants of individual variability of response to antiplatelet drugs
    Andrew I Schafer
    Circulation 108:910-1. 2003
  9. ncbi Physiologic cyclic stretch inhibits apoptosis in vascular endothelium
    Xiao-ming Liu
    VA Medical Center and the Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    FEBS Lett 541:52-6. 2003
    ..The ability of physiologic cyclic stretch to inhibit EC apoptosis may provide a previously unrecognized mechanism by which hemodynamic forces exert an anti-atherogenic effect...

Research Grants21

  1. REGULATION OF PLATELET/ENDOTHELIAL INTERACTIONS
    ANDREW SCHAFER; Fiscal Year: 2001
    ..The goal is to establish CO as an important vascular cell messenger molecule that modulates blood fluidity and may prove to be a target for therapy of vascular disorders. ..
  2. VASCULAR CELL CATIONIC AMINO ACID TRANSPORT & METABOLISM
    ANDREW SCHAFER; Fiscal Year: 2002
    ..Elucidation of the molecular mechanisms that modulate the response to vascular injury will provide new rational targets for therapeutic intervention. ..
  3. REGULATION OF PLATELET-ENDOTHELIAL INTERACTIONS
    ANDREW SCHAFER; Fiscal Year: 2006
    ....
  4. REGULATION OF PLATELET-ENDOTHELIAL INTERACTIONS
    ANDREW SCHAFER; Fiscal Year: 1993
    ..Understanding the modulation of platelet and EC actions and interactions by the fibrinolytic system will have pathophysiologic and pharmacologic importance in clarifying our concepts of thrombosis and hemostasis...
  5. Revitalization of the Nation?s Physician-Scientist Workforce
    ANDREW SCHAFER; Fiscal Year: 2007
    ..The conference is therefore only a starting point for implementing a long-term initiative for influencing and counteracting the decline in the physician-scientist workforce. ..